Publisher Correction: First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
Karim FizaziArun A AzadNobuaki MatsubaraJoan CarlesAndre P FayUgo De GiorgiJae Young JoungPeter C C FongEric VoogRobert J JonesNeal D ShoreCurtis DunsheeStefanie ZschäbitzJan OldenburgDingwei YeXun LinCynthia G HealyNicola Di SantoA Douglas LairdFabian ZohrenArchana M AgarwalPublished in: Nature medicine (2024)